1 min read

ID: 811036

Short Link: https://gregory-ms.com/articles/811036/

Discovery Date: 06 August 2022, 13:05:11 UTC

Published Date: 2022-08-05 10:00:00

Source: PubMed

Link: https://pubmed.ncbi.nlm.nih.gov/35931213/?utm_source=Other&utm_medium=rss&utm_campaign=pubmed-2&utm_content=10guX6I3SqrbUeeLKSTD6FCRM44ewnrN2MKKTQLLPMHB4xNsZU&fc=20210216052009&ff=20220806090507&v=2.17.7

Manual Selection: none

Machine Learning Gaussian Naive Bayes Model: false

Abstract

Tuberous sclerosis complex (TSC) is a genetic disorder involving a variety of physical manifestations, and is associated with epilepsy and multiple serious neuropsychiatric symptoms. These symptoms are collectively known as TSC-associated neuropsychiatric disorders (TAND), which is a severe burden for patients and their families. Overactivation of the mechanistic target of rapamycin complex 1 (mTORC1) by mutations in TSC1 or TSC2 is thought to cause TSC, and mTORC1 inhibitors such as sirolimus…

Noun Phrases in Title

  • Sirolimus
  • seizures
  • neuropsychiatric symptoms
  • changes
  • microglial polarity
  • tuberous sclerosis complex model mice
This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.